Search
Displaying 661–670 of 726 for “retinal diseases”
-
Coave Reports Encouraging Phase 1/2 Clinical Trial Results for PDE6B Gene Therapy
Research NewsThe company is expanding the trial to enroll younger patients with less advanced disease
-
Mental Health Awareness: Shattering the Stigma
WellnessAthletes around the world navigate the challenges of daily life and rigorous training, but what if a factor came into play that you had less control over? What if, one day, something changed in your vision?
-
The Foundation Fighting Blindness Peer Guide Program brings people who share common life experiences and goals together. Whether you live with a blinding retinal disease or have a family member or friend, the benefits are empowering. While working with a Peer Guide, they will direct you to some of the various resources
-
Research News
Most participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions
-
Resourceful Advocate for Research
Beacon StoriesManorthia was diagnosed with retinitis pigmentosa (RP) when she was 22 years old but didn’t start experiencing considerable vision loss until years later. Once she began to notice her vision deteriorating more rapidly, she reached out to the Foundation Fighting Blindness to get involved with the blindness community.
-
Eye on the Cure Podcast | Episode 35: Kenji Fujita, MD
Eye on the CureNovember 18, 2022. Ben Shaberman talks with Kenji Fujita, MD.
-
Beacon Stories My Retina Tracker Patient Stories
Mark Erelli has been a professional musician for the past twenty-three years. He’s always used songwriting to express himself. Since being diagnosed with retinitis pigmentosa, he’s needed music more than ever.
-
ProQR’s Sepofarsen Improves Vision Significantly for Girl with LCA10
Research NewsHowever, the Phase 2/3 Illuminate trial for sepofarsen didn’t meet its endpoints at 12 months
-
Enhanced Implantable Miniature Telescope Moving into Clinical Trial for AMD Patients
Research NewsThe device is designed for people with late-stage AMD who have no treatment options
-
Aldeyra Launches Phase 2 Clinical Trial of Methotrexate Intravitreal Injections for RP
Research NewsLab studies showed the drug can effectively address the misfolded rhodopsin protein
.png)
